Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: Effect of magnesium sulfate

Journal of Interferon and Cytokine Research

Volumn 32, Issue 9, 2012, Pages 432-441

  Amash, Alaa ^a   Holcberg, Gershon ^a,b   Sapir, Olga ^a,b   Huleihel, Mahmoud ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MAGNESIUM SULFATE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; PLACENTA; PLACENTA CIRCULATION; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MAGNESIUM SULFATE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; TOCOLYTIC AGENTS;

EID: 84866278626     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0013     Document Type: Article

References (43)

1. ACOG practice bulletin. 2002. Diagnosis and management of preeclampsia and eclampsia. Number 33. Obstet Gynecol 99:159-167.
2. Amash A, Holcberg G, Sheiner E, Huleihel M. 2010a. Magnesium sulfate normalizes placental interleukin-6 secretion in preeclampsia. J Interferon Cytokine Res 30:683-690.
3. Amash A, Weintraub AY, Sheiner E, Zeadna A, Huleihel M, Holcberg G. 2010b. Possible therapeutic effect of magnesium sulfate in pre-eclampsia by the down-regulation of placental tumor necrosis factor-alpha secretion. Eur Cytokine Netw 21:58-64.
4. Arend WP. 1991. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 88:1445-1451.
5. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. 2001. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 86:2505-2512. (Pubitemid 32545699)
6. Conrad KP, Benyo DF. 1997. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37:240-249. (Pubitemid 27149786)
7. Conrad KP, Miles TM, Benyo DF. 1998. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40:102-111.
8. Dammann O, Leviton A. 1997. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42:1-8. (Pubitemid 27276750)
9. Dinarello CA. 1994. The interleukin-1 family: 10 years of discovery. FASEB J 8:1314-1325.
10. Estellés A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Españ a F, Aznar J, Loskutoff DJ. 1998. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 79:500-508. (Pubitemid 28120779)
11. Faisel F, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Salonen J, Heinonen S. 2003. Polymorphism in the interleukin 1 receptor antagonist gene in women with preeclampsia. J Reprod Immunol 60:61-70. (Pubitemid 37272296)
12. Feinberg BB. 2006. Preeclampsia: the death of Goliath. Am J Reprod Immunol 55:84-98. (Pubitemid 43329483)
13. Girard S, Tremblay L, Lepage M, Sébire G. 2010. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol 184:3997-4005.
14. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. 1994. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 84:937-940. (Pubitemid 24360251)
15. Hefler LA, Tempfer CB, Gregg AR. 2001. Polymorphisms within the interleukin-1b gene cluster and preeclampsia. Obstet Gynecol 97:664-668.
16. Heyl W, Handt S, Reister F, Gehlen J, Schröder W, Mittermayer C, Rath W. 1999. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol 86:35-41. (Pubitemid 29333247)
17. Holcberg G, Amash A, Sapir O, Sheiner E, Levy S, Myatt L, Huleihel M. 2008. Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae. Placenta 29:593-601.
18. Holcberg G, Sapir O, Hallak M, Alaa A, Shorok HY, David Y, Katz M, Huleihel M. 2004. Selective vasodilator effect of magnesium sulfate in human placenta. Am J Reprod Immunol 51:192-197. (Pubitemid 38443576)
19. Kalinderis M, Papanikolaou A, Kalinderi K, Ioannidou E, Giannoulis C, Karagiannis V, Tarlatzis BC. 2011. Elevated serum levels of interleukin-6, interleukin-1b and human chorionic gonadotropin in pre-eclampsia. Am J Reprod Immunol 66:468-475.
20. Kharfi A, Giguère Y, Sapin V, Massé J, Dastugue B, Forest JC. 2003. Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 36:323-331. (Pubitemid 36776800)
21. Kimya Y, Akdisx C, Cengiz C, Ozan H, Tatlikazan S, Uncu G, Sengü l F. 1997. Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 73:17-21. (Pubitemid 27224455)
22. Koçyigit Y, Atamer Y, Atamer A, Tuzcu A, Akkus Z. 2004. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 19:267-273. (Pubitemid 40128859)
23. Krussel JS, Bielfeld P, Polan ML, Simon C. 2003. Regulation of embryonic implantation. Eur J Obstet Gynecol Reprod Biol 110 (Suppl 1):S2-S9. (Pubitemid 37072136)
24. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. 2007. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep 9: 480-485.
25. Lucas MJ, Leveno KJ, Cunningham FG. 1995. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 333:201-205.
26. Luppi P, Deloia JA. 2006. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118:268-275. (Pubitemid 43199666)
27. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. 1998. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 44:665-675. (Pubitemid 28477855)
28. Opsjøn SL, Austgulen R, Waage A. 1995. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand 74:19-26.
29. Page NM. 2002. The endocrinology of pre-eclampsia. Clin Endocrinol (Oxf) 57:413-423. (Pubitemid 35216293)
30. Paulesu L, Romagnoli R, Bigliardi E. 2005. Materno-fetal immunotolerance: is interleukin-1 a fundamental mediator in placental viviparity? Dev Comp Immunol 29:409-415. (Pubitemid 40222050)
31. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr., Bennett WA. 1999. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 181:915-920. (Pubitemid 29503615)
32. Roberts JM. 1995. Magnesium for preeclampsia and eclampsia. N Engl J Med 333:250-251.
33. Rochelson B,Dowling O, Schwartz N, Metz CN. 2007. Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway. J Reprod Immunol 73:101-107. (Pubitemid 46399949)
34. Rusterholz C, Gupta AK, Huppertz B, Holzgreve W, Hahn S. 2005. Soluble factors released by placental villous tissue: interleukin-1 is a potential mediator of endothelial dysfunction. Am J Obstet Gynecol 192:618-624. (Pubitemid 40215005)
35. Rusterholz C, Hahn S, Holzgreve W. 2007. Role of placentaly produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 29:151-162. (Pubitemid 47596394)
36. Shembrey MA, Noble AD. 1995. An instructive case of abdominal pregnancy. Aust N Z J Obstet Gynaecol 35:220-221.
37. Sibai BM, Caritis S, Hauth J. 2003. What we have learned about preeclampsia. Semin Perinatol 27:239-246. (Pubitemid 36828961)
38. Stallmach T, Hebisch G, Joller H, Kolditz P, Engelmann M. 1995. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions. Reprod Fertil Dev 7:1573-1580. (Pubitemid 26133270)
39. Szarka A, Rigó J Jr., Lázár L, Beko G, Molvarec A. 2010. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11:59.
40. Walker JJ. 2000. Pre-eclampsia. Lancet 356:1260-1265.
41. Witkin SS, Gerber S, Ledger WJ. 2002. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34:204-209. (Pubitemid 34028353)
42. Witlin AG, Sibai BM. 1998. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 92:883-889. (Pubitemid 28487694)
43. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Chio JH, Kim IO. 1997. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 177:19-26. (Pubitemid 27327305)